My Treatment Approach: Endometrial Carcinoma

home / insights / my-treatment-approach-endometrial-carcinoma

Expert gynecologic oncologists provide a discussion on the care of patients with endometrial carcinoma.

Endometrial Carcinoma: Clinical Scenario 1

EP. 1: Endometrial Carcinoma: Clinical Scenario 1

Krishnansu Tewari, MD;Bradley Monk, MD;David O’Malley, MD
March 4th 2022

Oncologists describe a typical presentation of endometrial carcinoma and debate the implications of radiation treatment.

Biomarker Testing in Endometrial Carcinoma

EP. 2: Biomarker Testing in Endometrial Carcinoma

Krishnansu Tewari, MD;Bradley Monk, MD, FACOG, FACS;David O'Malley, MD
March 4th 2022

An overview of biomarker testing in endometrial carcinoma.

Treatment Options for Advanced Stage Relapsed Endometrial Carcinoma

EP. 3: Treatment Options for Advanced Stage Relapsed Endometrial Carcinoma

Krishnansu Tewari, MD;Bradley Monk, MD, FACOG, FACS
March 10th 2022

Physician-researchers discuss the risk of recurrence in endometrial carcinoma and the available treatment options after relapse.

Dose Reduction in Endometrial Carcinoma Treatment

EP. 4: Dose Reduction in Endometrial Carcinoma Treatment

Krishnansu Tewari, MD;Bradley Monk, MD;David O’Malley, MD
March 10th 2022

Drs Bradley Monk and David O’Malley explain dose reduction in endometrial carcinoma treatment based on clinical trial data.

Endometrial Carcinoma: Clinical Case Scenario 2

EP. 5: Endometrial Carcinoma: Clinical Case Scenario 2

Krishnansu Tewari, MD;Bradley Monk, MD;David O’Malley, MD
March 18th 2022

Experts explain the need for germline testing and genetic counseling for patients with endometrial carcinoma as demonstrated by a patient case.

I/O + Chemotherapy Treatments for Endometrial Carcinoma

EP. 6: I/O + Chemotherapy Treatments for Endometrial Carcinoma

Krishnansu Tewari, MD;Bradley Monk, MD;David O'Malley, MD
March 18th 2022

A review of data from several clinical trials on the use of I/O + chemotherapy as treatment for endometrial carcinoma.

Trastuzumab in Endometrial Carcinoma Therapy

EP. 7: Trastuzumab in Endometrial Carcinoma Therapy

Krishnansu Tewari, MD;Bradley Monk, MD;David O'Malley, MD
March 24th 2022

Dr David O’Malley explains when to add and remove trastuzumab during endometrial carcinoma therapy.

Endometrial Carcinoma: Clinical Case Scenario 3

EP. 8: Endometrial Carcinoma: Clinical Case Scenario 3

Krishnansu Tewari, MD;David O’Malley, MD;Bradley Monk, MD, FACOG, FACS
March 24th 2022

Oncologists debate the proper treatment of a patient with a grade 2 endometrial carcinoma tumor.

Sequencing Therapy for MSI-High and MMR-Proficient Endometrial Carcinomas

EP. 9: Sequencing Therapy for MSI-High and MMR-Proficient Endometrial Carcinomas

Krishnansu Tewari, MD;Bradley Monk, MD;David O’Malley, MD
April 4th 2022

A discussion on the best way to sequence therapies for patients with MSI-high and MMR-proficient endometrial carcinoma.